We measured the rate of erythrocyte aggregation using our whole-blood aggregometer in 80 patients with occlusive cerebrovascular disease during the acute and chronic phases. We compared the data with values for 38 age-matched healthy controls. Mean±SD erythrocyte aggregability of the patients during both the acute phase (0.145 ± 0.021/sec, n=35) and the chronic phase (0.139±0.021/sec, ra=45) was higher than that in the controls (0.123±0.021/sec, n=38; /»<0.01). Erythrocyte aggregability was positively correlated with the plasma concentration of globulin and fibrinogen and inversely correlated with the albumin: globulin ratio. However, these correlations did not necessarily exclude the possibility that some unknown substance(s) released from ischemic tissue might enhance erythrocyte aggregability. (Stroke 1989;20:1202-1207)
H emorheologic factors have been discussed
in relation to the pathogenesis of cerebrovascular diseases (CVD). 1 -6 Erythrocyte (RBC) aggregability represents one of these factors since RBC aggregates are considered likely to plug the entrance to an arteriole or capillary, causing stasis in that part of the microvasculature of the cerebral tissue. Although some reports have suggested an increased RBC aggregability in CVD patients, 7 -9 no papers have yet compared RBC aggregability in such patients with that in agematched controls. Since RBC aggregability has been found to increase with age, especially age >50 years, 10 age-matched controls are considered obligatory in such studies. We describe such a study, using our whole-blood RBC aggregometer.
11

Subjects and Methods
We investigated 80 patients with occlusive CVD (35 in the acute phase [<21 days after onset] and 45 in the chronic phase [>1 month after onset]) and 38 age-matched healthy controls. The mean interval after onset for the acute-phase patients was 7 days, while that in the chronic-phase patients was 22 months. The mean±SD age of the acute-phase patients was 61 ±10 years and that of the chronicphase patients was 59±10 years; the mean±SD age of the controls was 59±9 years. For the 80 patients, occlusive CVD was diagnosed from the clinical history and computed tomography (CT) findings of the brain with corresponding neurologic signs. Details of the type of occlusive CVD (thrombotic or embolic), location and size of the infarct by CT scan, state of consciousness on measurement of RBC aggregability, and risk factors are given for the acute-phase patients in Table 1 and for the chronicphase patients in Table 2 . One patient (No. 31) died of brain edema on Day 18 of hospitalization. The controls comprised individuals who were visiting the hospital for their annual physical checkup. The controls had no history of circulatory disorders and no abnormalities on electrocardiography, chest xray, urinalysis, blood chemistry, or blood pressure.
In each subject, 10 ml venous blood was obtained (usually from the antecubital vein) and ethylenediaminetetraacetic acid was added as an anticoagulant. One milliliter was used to measure the RBC aggregation rate (aggregability) using the wholeblood RBC aggregometer developed by us.
11 Briefly, blood introduced into a transparent tube (0.26 cm i.d.) was automatically subjected to a shear rate of approximately 500 sec" 1 followed by a sudden stoppage. The subsequent changes in optical density of the blood due to formation of RBC aggregates were recorded with an apparatus 11 using infrared light Pt, patient; M, male; F, female; T, thrombotic; E, embolic; C, carotid system; VB, vertebrobasilar system; S, small, maximum diameter <15 mm; M, medium; L, large, extends to one or more lobes; A, alert; D, disturbed; HT, hypertension; AF, atrial fibrillation; DM, diabetes mellitus. and a silicon photodiode. The rate constant of the observed exponential change during the initial 20 seconds was calculated using a simple but new mathematical strategy that eliminated the error due to the unstable baseline problem. 11 The remainder of the blood sample was examined for its hemoglobin; hematocrit; RBC, leukocyte, and platelet counts; total protein, albumin, globulin, and fibrinogen concentrations; and albumin: globulin (A:G) ratio, and the data obtained were correlated with RBC aggregability. Changes were analyzed by Student's unpaired t test. In seven patients (Nos. 1, 5, 8, 13, 14, 20, and 21), RBC aggregability was measured twice, during both the acute and the chronic phases, to examine its changes over time after the occlusive insult.
Results RBC aggregability in individual acute-phase patients are listed in Table 1 and in individual chronic-phase patients in Table 2 . Mean±SD RBC aggregability was 0.123±0.021/sec in the controls, 0.145±0.021/sec in the acute-phase patients, and 0.139±0.021/sec in the chronic-phase patients. There was a significant increase of RBC aggregability in both groups of patients with occlusive CVD compared with controls ( Figure 1 ). Mean RBC aggregability in the chronic-phase patients was lower than Pt, patient; M, male; F, female; small, maximum diameter <15 mm; hypertension; AF, atrial fibrillation T, thrombotic; E, embolic; C, carotid system; VB, M, medium; L, large, extends to one or more lobes; ; DM, diabetes mellitus. vertebrobasilar system; S, A, alert; D, disturbed; HT, that in the acute-phase patients, but the difference was not significant. However, when RBC aggregability in a patient was followed over time (Figure 2) , the enhanced RBC aggregability in the acute phase was significantly reduced (p<0.05 by Student's paired t test) in the chronic phase. FIGURE 
Scatter plot comparing individual and group mean±SD rates of erythrocyte aggregation (RBC-A) among 38 healthy controls matched for age with 35 patients in acute phase of occlusive cerebrovascular disease (CVD) and 45 patients in chronic phase of occlusive CVD. RBC-A was significantly higher in patients with acute or chronic CVD.
RBC aggregability was not correlated with type of occlusive CVD, location or size of the infarct, or state of consciousness. Associated laboratory data are listed in Table 3 . There were significant increases in the leukocyte count and a 2 -globulin and fibrinogen concentrations and significant decreases in hematocrit, albumin concentration, and the A^G ratio in the acute-phase patients compared with the controls. The relations between RBC aggregability Values are mean±SD. *tp<0.05, 0.01, respectively, different from controls by Student's t test. and hematocrit and globulin and fibrinogen concentrations are shown in Figures 3, 4 , and 5, respectively. Significant positive linear correlations were noted between RBC aggregability and globulin and fibrinogen concentrations, and a significant negative linear correlation was observed between RBC aggregability and the A^G ratio. Table 4 summarizes the blood factor data correlated with RBC aggregability in both the acute-and chronic-phase groups of patients with occlusive CVD. 
Discussion
Our findings of RBC hyperaggregability in patients with occlusive CVD suggest that local events in cerebral ischemia could cause changes in RBC aggregability of the systemic circulating blood. Reid et al 12 reported that RBC deformability was impaired in peripheral vascular disease. Dintenfass 13 found that the thixotropy and viscosity of blood were up to 10-fold greater in patients suffering from thrombosis and coronary occlusion; he ascribed these increases at low shear rates to enhanced RBC aggregation. RBC hyperaggregability has also been reported in patients with diabetes mellitus, which is known to be one of the risk factors for stroke.
14 The question of whether RBC hyperaggregability during the acute and chronic phases of occlusive CVD that we found is the result of the ischemic insult itself or an existing factor predating the insult is clearly of essential importance in handling stroke patients with occlusive CVD. We have found that RBC aggregability becomes enhanced <1 hour after middle cerebral artery occlusion in cats (unpublished data reported at the First European Congress of Neurology, April 1988, Prague, Czechoslovakia). Therefore, the ischemic insult per se could somehow cause RBC hyperaggregability during the acute phase of occlusive CVD either through concomitant changes in blood constituents (e.g., increased fibrinogen concentration) or as a result of some unknown substance(s) released from the aggregated platelets or the ischemic tissue. However, we cannot exclude the possibility of a predisposition to stroke with abnormal blood protein constituents that may aggravate microcirculatory derangement upon arterial occlusion. In such a case, enhanced RBC aggregability might even reflect a precursor state of thrombosis, which could lead to cerebral ischemia.
